<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003257113
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PROPECIA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FINASTERIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        110.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="AIAC INTERNATIONAL PHARMA LLC" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            AIAC INTERNATIONAL PHARMA LLC
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Organon Pharma UK Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G04CB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:6.0pt; margin-right:68.05pt">Propecia contains a medicine called finasteride. This belongs to a group of medicines called Type II &lsquo;5-alpha reductase inhibitors&rsquo;.</p><p style="margin-left:6.0pt; margin-right:46.55pt">Propecia is used for the treatment of male pattern hair loss (also known as androgenetic alopecia). Propecia increases hair growth on the scalp and prevents further hair loss in men. Men with mild to moderate, but not complete hair loss, can benefit from using Propecia.</p><p>How does the hair on your head grow?</p><p style="margin-right:68.05pt">On average your hair grows about 1 centimetre (half an inch) each month. Hair grows from hair follicles, which are located under your skin.</p><p style="margin-left:6.0pt; margin-right:68.05pt">A single scalp hair grows continuously for 2-4 years (growth phase) and then stops growing for 2-4 months (rest phase). After this the hair falls out. In its place a new healthy hair begins to grow, and the cycle is repeated. The hairs on your scalp are always in different stages of this cycle so it is normal to lose scalp hair every day.</p><p>What is male pattern hair loss?</p><p style="margin-right:57.35pt; text-align:justify">Male pattern hair loss is a common condition in which men experience thinning of the hair on the scalp, often resulting in a receding hairline and/or balding on the top of the head. This condition is thought to be caused by a combination of genetic factors and a particular hormone, DHT (dihydrotestosterone).</p><p>&nbsp;</p><p>&nbsp;</p><p style="margin-left:6.0pt; margin-right:8.5pt">DHT causes a decrease in the growth phase and thinning of the hair (see picture). This leads to male pattern hair loss. These changes can start to occur in some men in their 20s and become more common with age. Once hair loss has occurred over a long period of time, the hair may be permanently lost.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p style="margin-left:129.45pt"><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="image1.jpeg" o:spid="_x0000_i1025" type="#_x0000_t75"
 style='width:207pt;height:153pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/albalawi/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
  o:title=""/>
</v:shape><![endif]--><!--[if !vml]--><img width="276" height="204" src="file:///C:/Users/albalawi/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg" /><!--[endif]--></p><p>How does Propecia work?</p><p style="margin-right:14.35pt">Propecia lowers the levels of DHT in the scalp. This helps to reverse the balding process, leading to an increased hair growth and prevention of further hair loss.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Propecia:</p><p style="margin-left:20.15pt; margin-right:15.95pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you are a woman (because this medicine is for men). It has been shown in clinical trials that Propecia does not work in women with hair loss.</p><p style="margin-left:20.15pt; margin-right:27.6pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you are allergic (hypersensitive) to finasteride or any of the other ingredients of this medicine (listed in Section 6).</p><p style="margin-left:20.15pt; margin-right:13.65pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If you are already taking finasteride or dutasteride used for a prostate problem called benign prostatic hyperplasia (BPH).</p><p style="margin-right:8.5pt">Do not take Propecia if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist.</p><p>Warnings and Precautions</p><p>Talk to your doctor or pharmacist before taking Propecia if:</p><p style="margin-left:20.15pt; margin-right:19.3pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->You are going to have a blood test for prostate cancer called PSA (prostate-specific antigen). This is because Propecia can affect the result of this test.</p><p>&nbsp;</p><p>Effects on fertility</p><p style="margin-right:14.35pt">Infertility has been reported in men who took finasteride for long time and had other risk factors that may affect fertility. Normalisation or improvement of seminal quality has been reported after discontinuation of finasteride. Long-term clinical studies about the effects of finasteride on fertility in men have not been conducted.</p><p>&nbsp;</p><p>Breast Cancer</p><p>See section 4.</p><p>&nbsp;</p><p>Mood alterations and depression</p><p style="margin-right:8.5pt">Mood alterations such as depressed mood, depression and, less frequently, suicidal thoughts have been reported in patients treated with Propecia. If you experience any of</p><p>&nbsp;</p><p style="margin-left:6.0pt; margin-right:4.05pt">these symptoms stop taking Propecia and contact your doctor for further medical advice as soon as possible.</p><p>&nbsp;</p><p>Children and adolescents</p><p style="margin-right:8.5pt">Propecia should not be used in children. There are no data demonstrating efficacy or safety of finasteride in children under the age of 18.</p><p>&nbsp;</p><p>Other medicines and Propecia</p><p style="margin-right:8.5pt">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Propecia does not usually affect other medicines.</p><p style="margin-left:20.15pt; margin-right:.25in; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Do not take Propecia if you are already taking finasteride or dustasteride, used for a prostate problem called benign prostatic hyperplasia (BPH).</p><p style="margin-left:20.15pt; margin-right:11.1pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->No information is available about the use of Propecia with minoxidil, another type of medicine for male pattern hair loss which is applied to the head.</p><p>Pregnancy, breast feeding and fertility</p><p style="margin-left:6.0pt; margin-right:14.35pt"><strong>Propecia</strong><strong> </strong><strong>is</strong><strong> </strong><strong>for</strong><strong> </strong><strong>the</strong><strong> </strong><strong>treatment</strong><strong> </strong><strong>of</strong><strong> </strong><strong>male</strong><strong> </strong><strong>pattern</strong><strong> </strong><strong>hair</strong><strong> </strong><strong>loss</strong><strong> </strong><strong>in</strong><strong> </strong><strong>men</strong><strong> </strong><strong>only.</strong><strong> </strong><strong>For</strong><strong> </strong><strong>effects</strong><strong> </strong><strong>on</strong><strong> </strong><strong>fertility</strong><strong> </strong><strong>see</strong><strong> </strong><strong>section</strong><strong> </strong><strong>2.</strong></p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>Propecia</strong><strong> </strong><strong>should</strong><strong> </strong><strong>not</strong><strong> </strong><strong>be</strong><strong> </strong><strong>taken</strong><strong> </strong><strong>by</strong><strong> </strong><strong>women</strong>.</p><p style="margin-left:20.15pt; margin-right:32.55pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>Do</strong><strong> </strong><strong>not</strong><strong> </strong><strong>touch</strong><strong> </strong><strong>crushed</strong><strong> </strong><strong>or</strong><strong> </strong><strong>broken</strong><strong> </strong><strong>Propecia</strong><strong> </strong><strong>tablets</strong><strong> </strong><strong>if</strong><strong> </strong><strong>you</strong><strong> </strong><strong>are</strong><strong> </strong><strong>a woman who is pregnant or planning to become pregnant (whole tablets are coated to stop contact with the medicine during normal use). This is because this medicine may affect the baby&rsquo;s sex organs</strong>.</p><p style="margin-left:20.15pt; margin-right:32.5pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If a woman who is pregnant comes into contact with crushed or broken Propecia tablets, speak to your doctor.</p><p>Driving and using machines</p><p>Propecia is not likely to affect you being able to drive, use tools or machines.</p><p>Propecia contains Lactose</p><p style="margin-right:14.35pt">If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:6.0pt; margin-right:8.5pt">Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p style="margin-left:20.15pt; margin-right:35.5pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The recommended dose is one tablet each day. The tablet can be taken with or without food.</p><p>If you take more Propecia than you should</p><p style="margin-right:8.5pt">If you take too many tablets by mistake, contact your doctor immediately. Propecia will not work faster or better if you take it more than once a day.</p><p>If you forget to take Propecia</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Do not take a double dose to make up for a forgotten dose.</p><p>If you stop taking Propecia</p><p style="margin-right:14.35pt">It may take 3 to 6 months for the full effect to develop. It is important to keep taking Propecia for as long as your doctor tells you. If you stop taking Propecia, you are likely to lose the hair you have gained within 9 to 12 months.</p><p style="margin-left:6.0pt; margin-right:14.35pt">If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-right:11.1pt">Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the side effects are temporary with continued treatment or disappeared when treatment is stopped.</p><p>&nbsp;</p><p>Stop taking Propecia and talk to your doctor if you experience:</p><p style="margin-left:20.15pt; margin-right:15.95pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Symptoms of an allergic reaction: swelling of your lips, face, tongue and throat; difficulty swallowing; lumps under your skin (hives) and breathing difficulties. Stop taking Propecia and talk to your doctor immediately.</p><p style="margin-left:20.15pt; margin-right:0in; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Depression (feeling of severe sadness and unworthiness).</p><p>&nbsp;</p><p style="margin-right:14.35pt">You should promptly report to your doctor any changes in your breast tissue such as lumps, pain, enlargement or nipple discharge as these may be signs of a serious condition, such as breast cancer.</p><p>&nbsp;</p><p>Uncommon: may affect up to 1 in 100 people</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->you may be unable to have an erection (impotence)</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->you may have less desire to have sex</p><p style="margin-left:20.15pt; margin-right:15.95pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->you may have problems with ejaculation, for example a decrease in the amount of semen released during sex. This decrease in the amount of semen does not appear to affect normal sexual function</p><p>Frequency unknown:</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->breast swelling or tenderness</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->palpitations (feeling your heartbeat)</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->changes in the way your liver is working, which can be shown by a blood test</p><p style="margin-left:20.15pt; margin-right:0in; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->pain in the testicles</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->persistent difficulty having an erection after discontinuation of treatment</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->persistent decrease in sex drive after discontinuation of treatment</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->persistent problems with ejaculation after discontinuation of treatment</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->male infertility and/or poor quality of semen</p><p style="margin-left:20.15pt; margin-right:0in; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->anxiety</p><p>&nbsp;</p><p style="margin-right:9.85pt; text-align:justify">If any of these side effects gets serious, or if you notice any side effects not listed on this leaflet please tell your doctor or pharmacist. It will help if you make a note of what happened, when it started and how long it lasted.</p><p>&nbsp;</p><p>Will the use of Propecia affect the hair on other parts of your body?</p><p>Propecia does not affect hair on other parts of the body.</p><p>What else should you know about Propecia?</p><p style="margin-right:14.35pt">Finasteride can also be used for a type of prostate problem called &lsquo;benign prostatic hyperplasia&rsquo; or BPH. Information collected from a clinical trial in men taking finasteride 5 mg (a dose 5 times higher than Propecia) for 7 years showed:</p><p style="margin-left:20.15pt; margin-right:47.9pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the number of men who developed prostate cancer was lower in men taking finasteride compared with those taking nothing</p><p style="margin-left:20.15pt; margin-right:13.65pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the number of men who had a high score in a tumour grading system was higher in some of those taking finasteride compared to those taking nothing</p><p style="margin-left:20.15pt; text-indent:-14.15pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the effect of long-term use of finasteride on tumours of this kind is unknown.</p><p>&nbsp;</p><p>&nbsp;</p><p style="margin-left:6.0pt; margin-right:8.5pt">If you would like further information about the tumour grading system or this trial, please talk to your doctor.</p><p>&nbsp;</p><p>&nbsp;</p><p>Reporting of side effects</p><p style="margin-right:14.35pt">If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (The National Pharmacovigilance and Drug Safety Centre (NPC), SFDA). By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p style="margin-left:6.0pt; margin-right:14.35pt">Do not use this medicine after the expiry date which is stated on the carton after the letters EXP. The expiry date refers to the last day of that month.</p><p style="margin-left:6.0pt; margin-right:14.35pt">Do not put the tablets into another container, they might get mixed up. Do not remove the tablet from the pack until you are ready to take it.</p><p>Store below 30&deg;C. Store in the original package.</p><p style="margin-left:6.0pt; margin-right:15.95pt">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Propecia contains</p><p style="margin-left:24.0pt; text-indent:-.25in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The active substance is finasteride. Each tablet contains 1 mg finasteride.</p><p style="margin-left:24.0pt; margin-right:15.95pt; text-indent:-.25in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The other ingredients are: lactose, microcrystalline cellulose E460, pregelatinised maize starch, sodium starch glycollate, docusate sodium, magnesium stearate E572, hypromellose E464, hydroxypropyl cellulose E463, titanium dioxide, talc, yellow iron oxide E172, red iron oxide E172.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Propecia looks like and the content of the pack.
•	Propecia is available as tan, eight-sided, film-coated tablets, marked with a ‘P’ logo on one side and PROPECIA on the other.
•	Propecia Tablets are supplied in blister packs of 28 tablets or 84 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:6.0pt; margin-right:-1.0pt"><strong>Marketin</strong><strong>g Authorization Holder </strong></p><p style="margin-left:6.0pt; margin-right:-1.0pt">Merck Sharp &amp; Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, UK.</p><p>&nbsp;</p><p style="margin-left:6.0pt; margin-right:33.7pt"><strong>Manufacture</strong><strong>r:</strong></p><p style="margin-left:6.0pt; margin-right:-1.0pt">AIAC International Pharma LLC,</p><p style="margin-left:6.0pt; margin-right:-1.0pt">Road No 2, Kilometer&nbsp; 60.3, Sabana Hoyos,</p><p style="margin-left:6.0pt; margin-right:-1.0pt">Arecibo, PR-00688,</p><p style="margin-left:6.0pt; margin-right:-1.0pt">Puerto Rico -USA</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in May 2018.
Version No. (03)

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="margin-right:13.5pt; text-indent:-.25in" dir="RTL"><!--[if !supportLists]--><strong>1.&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]--><strong>ما هو بروبيشيا و ما هي دواعي إستعماله</strong></p><p style="margin-right:-4.5pt" dir="RTL">بروبيشيا يحتوي على دواء يسمى فيناسترايد، وهو ينتمي إلى مجموعة من الأدوية تسمى&nbsp; &quot;النوع ۲ من مثبطات مختزلات ٥ الفا&quot;.</p><p style="margin-right:-4.5pt" dir="RTL">لقد وصف لك طبيبك بروبيشيا لأن لديك النمط الذكوري لفقدان الشعر( كما يُعرف أيضا بالصلع الهرموني الوراثي). بروبيشيا يزيد نمو الشعر على فروة الرأس ويمنع المزيد من فقدان الشعر لدى الرجال. الرجال المصابين بفقدان خفيف إلى متوسط، ولكن لم يكتمل فقدان الشعر لديهم، يستطيعون الاستفادة من استخدام بروبيشيا.</p><p style="margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL"><strong>كيف ينمو شعر رأسك؟</strong></p><p style="margin-right:-4.5pt" dir="RTL">في المتوسط ينمو شعرك بحوالي ۱ سنتيميتر (نصف بوصة) كل شهر. وينمو الشعر من بصيلات الشعر، والتي تقع تحت جلدك.</p><p style="margin-right:-4.5pt" dir="RTL">تنمو شعرة فروة الرأس الواحدة بشكل مستمر لمدة ۲-٤ سنوات (مرحلة النمو) وبعد ذلك يتوقف النمو لمدة ۲-٤ أشهر (مرحلة الاستراحة)، بعد ذلك يتساقط الشعر. وتبدأ شعرة صحية جديدة في النمو بمكانها، وتتكرر الدورة. يمر الشعر في&nbsp; فروة رأسك دائماً بمراحل مختلفة من هذه الدورة ولذلك من الطبيعي أن يتساقط شعر رأسك كل يوم.</p><p style="margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL"><strong>ما هو النمط الذكوري لتساقط الشعر؟</strong></p><p style="margin-right:-4.5pt" dir="RTL">النمط الذكوري لتساقط الشعر هو حالة شائعة في الرجال حيث يصابون بخفة الشعر في فروة الرأس، وغالباً ما يؤدي إلى انحسار خطوط الشعر و/ أو الصلع في أعلى الرأس. ويعتقد بأن هذه الحالة ناجمة عن تضافر عوامل وراثية وهرمون خاص، دي اتش تي ( دايهدروتستوستيرون).</p><p style="margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL">دي اتش تي يسبب نقص في&nbsp; مرحلة النمو ويؤدي إلى تخفيف الشعر(انظر الصورة). هذا يؤدي إلى النمط الذكوري في فقدان الشعر. هذه التغييرات يمكن أن تبدأ في الحدوث عند بعض الرجال في العشرينات وتصبح أكثر شيوعاً مع التقدم في العمر. مجرد أن يحدث تساقط للشعر على مدى فترة طويلة من الزمن، ممكن أن يتساقط الشعر نهائياً.</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:273.55pt; vertical-align:top; width:436.3pt"><p style="margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL"><!--[if gte vml 1]><v:shapetype id="_x0000_t202"
   coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
   <v:stroke joinstyle="miter"/>
   <v:path gradientshapeok="t" o:connecttype="rect"/>
  </v:shapetype><v:shape id="Text_x0020_Box_x0020_2" o:spid="_x0000_s1026"
   type="#_x0000_t202" style='position:absolute;left:0;text-align:left;
   margin-left:147.85pt;margin-top:10.5pt;width:99.8pt;height:22.35pt;
   z-index:251655680;visibility:visible;mso-width-relative:margin;
   mso-height-relative:margin' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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">
   <v:textbox style='mso-next-textbox:#Text_x0020_Box_x0020_2'/>
  </v:shape><![endif]--><!--[if !vml]--></p><table align="left" cellspacing="0" cellpadding="0"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td style="background-color:white; border-color:black; vertical-align:top"><!--[endif]--><!--[if !mso]--><table style="width:100%" cellspacing="0" cellpadding="0"><tbody><tr><td><!--[endif]--><p style="text-align:center" dir="RTL">دايهدرو تستوستيرون</p><p dir="RTL">&nbsp;</p><!--[if !mso]--></td></tr></tbody></table><!--[endif]--><!--[if !mso & !vml]-->&nbsp;<!--[endif]--><!--[if !vml]--></td></tr></tbody></table><!--[endif]-->&nbsp;<p>&nbsp;</p>&nbsp;<p style="margin-right:-4.5pt" dir="RTL"><!--[if gte vml 1]><v:shape id="_x0000_s1028" type="#_x0000_t202"
   style='position:absolute;left:0;text-align:left;margin-left:354.15pt;
   margin-top:114.9pt;width:63.75pt;height:41pt;z-index:251657728;visibility:visible;
   mso-width-relative:margin;mso-height-relative:margin' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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">
   <v:textbox style='mso-next-textbox:#_x0000_s1028'/>
  </v:shape><![endif]--><!--[if !vml]--></p><table cellspacing="0" cellpadding="0"><tbody><tr><td style="background-color:white; border-color:black; vertical-align:top"><!--[endif]--><!--[if !mso]--><table style="width:100%" cellspacing="0" cellpadding="0"><tbody><tr><td><!--[endif]--><p style="text-align:center" dir="RTL">نمط ذكوري لتساقط الشعر</p><p dir="RTL">&nbsp;</p><!--[if !mso]--></td></tr></tbody></table><!--[endif]--><!--[if !mso & !vml]-->&nbsp;<!--[endif]--><!--[if !vml]--></td></tr></tbody></table> <!--[endif]--><!--[if gte vml 1]><v:shape id="_x0000_s1030" type="#_x0000_t202"
   style='position:absolute;left:0;text-align:left;margin-left:98.15pt;
   margin-top:68pt;width:134.65pt;height:21.7pt;z-index:251659776;visibility:visible;
   mso-width-relative:margin;mso-height-relative:margin' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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">
   <v:textbox style='mso-next-textbox:#_x0000_s1030'/>
  </v:shape><![endif]--><!--[if !vml]--><table cellspacing="0" cellpadding="0"><tbody><tr><td style="background-color:white; border-color:black; vertical-align:top"><!--[endif]--><!--[if !mso]--><table style="width:100%" cellspacing="0" cellpadding="0"><tbody><tr><td><!--[endif]--><p style="text-align:center">شعر صحي (سميك، ينمو بشكل طبيعي، ولون كامل)</p><p dir="RTL">&nbsp;</p><!--[if !mso]--></td></tr></tbody></table><!--[endif]--><!--[if !mso & !vml]-->&nbsp;<!--[endif]--><!--[if !vml]--></td></tr></tbody></table> <!--[endif]--><!--[if gte vml 1]><v:shape id="_x0000_s1029" type="#_x0000_t202"
   style='position:absolute;left:0;text-align:left;margin-left:278.35pt;
   margin-top:56.75pt;width:106.75pt;height:32.95pt;z-index:251658752;
   visibility:visible;mso-width-relative:margin;mso-height-relative:margin'
   o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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">
   <v:textbox style='mso-next-textbox:#_x0000_s1029'/>
  </v:shape><![endif]--><!--[if !vml]--><table cellspacing="0" cellpadding="0"><tbody><tr><td style="background-color:white; border-color:black; vertical-align:top"><!--[endif]--><!--[if !mso]--><table style="width:100%" cellspacing="0" cellpadding="0"><tbody><tr><td><!--[endif]--><p style="text-align:center" dir="RTL">قلة كثافة الشعر المستمرة (الشعرة أخف، وأقصر وأقل لون)</p><p dir="RTL">&nbsp;</p><!--[if !mso]--></td></tr></tbody></table><!--[endif]--><!--[if !mso & !vml]-->&nbsp;<!--[endif]--><!--[if !vml]--></td></tr></tbody></table> <!--[endif]--><!--[if gte vml 1]><v:shape id="_x0000_s1027" type="#_x0000_t202"
   style='position:absolute;left:0;text-align:left;margin-left:103.9pt;
   margin-top:163.4pt;width:108.25pt;height:22.35pt;z-index:251656704;
   visibility:visible;mso-width-relative:margin;mso-height-relative:margin'
   o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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">
   <v:textbox style='mso-next-textbox:#_x0000_s1027'/>
  </v:shape><![endif]--><!--[if !vml]--><table cellspacing="0" cellpadding="0"><tbody><tr><td style="background-color:white; border-color:black; vertical-align:top"><!--[endif]--><!--[if !mso]--><table style="width:100%" cellspacing="0" cellpadding="0"><tbody><tr><td><!--[endif]--><p style="text-align:center" dir="RTL">لا يوجد نمط ذكوري لتساقط الشعر</p><p dir="RTL">&nbsp;</p><!--[if !mso]--></td></tr></tbody></table><!--[endif]--><!--[if !mso & !vml]-->&nbsp;<!--[endif]--><!--[if !vml]--></td></tr></tbody></table> <!--[endif]--><!--[if gte vml 1]><v:shapetype
   id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
   path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
   <v:stroke joinstyle="miter"/>
   <v:formulas>
    <v:f eqn="if lineDrawn pixelLineWidth 0"/>
    <v:f eqn="sum @0 1 0"/>
    <v:f eqn="sum 0 0 @1"/>
    <v:f eqn="prod @2 1 2"/>
    <v:f eqn="prod @3 21600 pixelWidth"/>
    <v:f eqn="prod @3 21600 pixelHeight"/>
    <v:f eqn="sum @0 0 1"/>
    <v:f eqn="prod @6 1 2"/>
    <v:f eqn="prod @7 21600 pixelWidth"/>
    <v:f eqn="sum @8 21600 0"/>
    <v:f eqn="prod @7 21600 pixelHeight"/>
    <v:f eqn="sum @10 21600 0"/>
   </v:formulas>
   <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
   <o:lock v:ext="edit" aspectratio="t"/>
  </v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:305.5pt;
   height:191pt'>
   <v:imagedata src="file:///C:/Users/albalawi/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img width="407" height="255" src="file:///C:/Users/albalawi/AppData/Local/Temp/msohtmlclip1/01/clip_image002.jpg" /><!--[endif]--><p>&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL">&nbsp;</p></td></tr></tbody></table><p style="margin-right:-4.5pt; text-align:left" dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL"><strong>كيف يعمل بروبيشيا؟</strong></p><p style="margin-right:-4.5pt" dir="RTL">بروبيشيا يخفض مستويات دي اتش تي في فروة الرأس. وهذا يساعد على عكس عملية الصلع، مما يؤدي إلى زيادة نمو الشعر ومنع المزيد من فقدان الشعر.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="margin-right:-4.5pt" dir="RTL"><strong>لا تتناول بروبيشيا إذا</strong>:</p><p style="margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->&nbsp;كنت امرأة ( لأن هذا الدواء مخصص للذكور فقط ).&nbsp; فقد تبين في التجارب السريرية أن بروبيشيا لا يعمل مع النساء في حالة فقدان الشعر.</p><p style="margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كانت لديك حساسية ( حساسية مفرطة) للـفيناسترايد أو أي من المكونات الأخرى (المدرجة في البند ٦).</p><p style="margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كنت بالفعل تتناول فيناسترايد أو دوتاستيرايد المستخدمة لعلاج مشكلة البروستاتا التي تسمى تضخم البروستاتا الحميد (بي بي اتش).</p><p style="margin-right:-4.5pt" dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتناول بروبيشيا إذا أي مما ذُكر أعلاه ينطبق عليك. إذا كنت غير متأكد، اخبر طبيبك أو الصيدلي.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>&nbsp;يجب توخي الحذر عند تناول بروبيشيا :</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">تحقق من طبيبك أو الصيدلي قبل تناولك لدوائك إذا كنت ستؤدي فحص دم لسرطان البروستاتا يسمى PSA ( مستضد البروستاتا المحدد). لأن بروبيشيا قد يؤثر على نتيجة الاختبار.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>التأثير على الخصوبة</strong><br />تم الإبلاغ عن حالات لقلة الخصوبة في الذكور الذين تناولوا فيناسترايد لمدة طويلة وكانت لديهم عوامل خطورة أخرى تهدد الخصوبة. وتم تم الإبلاغ عن عودة الجودة للحيوانات المنوية إلى طبيعتها أو تحسنها بعد توقف العلاج بفيناسترايد. ولم تجرى دراسات طويلة الأمد تبحث تأثير الفيناسترايد على خصوبة الرجل.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>سرطان الثدي</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">انظر البند 4.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>تغييرات المزاج والاكتئاب</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">تغييرات المزاج مثل الاكتئاب ، و قد تم الإبلاغ&nbsp; بوتيرة أقل عن أفكار انتحارية في المرضى الذين تناولوا بروبيشيا. إذا كنت تواجه أي من هذه الأعراض، &nbsp;توقف عن أخذ بروبيشيا واتصل بطبيبك لمزيد من المشورة الطبية بالسرعة الممكنة.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>الاطفال والمراهقين </strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">يجب ان لايستخدم بروبيشيا من قبل الاطفال. لا توجد بيانات تثبت فعالية أو سلامة فيناسترايد في الأطفال الذين تقل أعمارهم عن 18 عاما.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>تناول أدوية أخرى</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">بروبيشيا عادة لا يؤثر على الأدوية الأخرى. دائماً اخبر طبيبك او الصيدلي عن الأدوية التي تتناولها او تناولتها مؤخرا، أو التي تنوي تناولها، بما في ذلك الأدوية التي تعطى بدون وصفة طبية.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا تتناول بروبيشيا إذا كنت بالفعل تتناول فيناسترايد أو دوتاستيرايد التي تستخدم لمشكلة البروستاتا والتي تسمى تضخم البروستاتا الحميد (بي بي اتش).</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا تتوفر معلومات حول استخدام بروبيشيا مع مينوكسيديل، نوع آخر من الأدوية المستخدمة للنمط الذكوري لفقدان الشعر والذي يوضع على الراس.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>الحمل والإرضاع ، والخصوبة :</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">يستخدم بروبيشيا للنمط الذكوري لفقدان الشعر في الرجال فقط . التأثير على الخصوبة انظر البند 2</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا يجب تناول بروبيشيا من قبل النساء.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا تلمسي أقراص بروبيشيا المسحوقة أو المتكسرة إذا كنتِ امرأة حامل أو لديك النية لأن تكوني حامل (أقراص بروبيشيا مغلفة لتحول بين ملامسته أثناء التناول الاعتيادي)، وذلك لان هذا الدواء قد يؤثر على نمو أعضاء الجنين الجنسية.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->اخبر الطبيب إذا تعرضت المرأة الحامل لأقراص مسحوقة أو متكسرة من بروبيشيا،</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>&nbsp; القيادة واستعمال الآلات:</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp; ليس من المحتمل أن يؤثر بروبيشيا على قدرتك على القيادة، أو استخدام الأدوات أو الآلات.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>يحتوي بروبيشيا على لاكتوز</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;إذا أخبرك طبيبك من قبل انه لا يمكنك تقبل أو هضم بعض السكريات، ( لديك عدم تقبل أو تحسس لبعض السكريات)، اخبر طبيبك قبل تناول هذا الدواء.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">دائماً تناول بروبيشيا كما أخبرك الطبيب او الصيدلي تماماً، تحقق من طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->الجرعة المعتادة هي قرص واحد كل يوم. يمكن تناول القرص مع او بدون الطعام.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>&nbsp;إذا تناولت بروبيشيا أكثر مما ينبغي:</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;إذا تناولت الكثير من الأقراص عن طريق الخطأ، اخبر طبيبك في الحال. بروبيشيا لن يعمل بشكل أسرع أو أفضل إذا تناولته أكثر من مرة واحدة يومياً</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>&nbsp;إذا نسيت تناول بروبيشيا:</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>&nbsp; إذا انقطعت عن تناول بروبيشيا:</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp; إن الأمر قد يستغرق من ۳-٦ أشهر لظهور التأثير الكامل. من المهم الحفاظ على تناول بروبيشيا على طول المدة التي يوصيك بها الطبيب. إذا أوقفت تناول بروبيشيا، فمن المحتمل أن تفقد الشعر الذي اكتسبته خلال ٩-۱۲ شهر.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;إذا كانت لديك إي أسئلة أخرى عن استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p><p style="margin-right:13.5pt" dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">مثل جميع الأدوية، بروبيشيا يمكن أن يسبب أعراض جانبية، على الرغم من أنها لا تحصل للجميع. بعض الأعراض الجانبية مؤقتة مع استمرار العلاج أو تختفي عند إيقاف العلاج.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">إذا كانت لديك &nbsp;أي حساسية، أوقف استخدام هذا الدواء وراجع طبيبك. الأعراض قد تشمل:</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورم في الشفاه والوجه، اللسان أو الحلق، صعوبة البلع، طفح جلدي، حكة، كتل تحت جلدك (حساسية الجلد)،صعوبة التنفس. توقف عن أخذ بروبيشيا واتصل بطبيبك</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->الاكتئاب (الشعور بالحزن الشديد وعدم الجدارة).</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;&nbsp;&nbsp; يجب إبلاغ الطبيب فورا عن أي تغيرات في نسيج الثدي لديك مثل كتل، والألم، وتضخم أو خروج &nbsp;إفرازات من الحلمة وهذه قد تكون دلائل على وجود حالة &nbsp;&nbsp;طيرة، مثل سرطان الثدي</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>&nbsp; </strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>غير شائعة : قد تصيب واحد من 100 شخص</strong></p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->ربما قد تصاب بعدم القدرة على الانتصاب (العنة).</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->قلة الرغبة في ممارسة الجنس.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->ربما قد تواجه مشاكل مع القذف. عل سبيل المثال، انخفاض كمية السائل المنوي الخارج أثناء ممارسة الجنس. هذا الانخفاض في كمية السائل المنوي لا يؤثر على العملية الطبيعية للجنس.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>&nbsp; التكرار غير معروف:</strong></p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->تورم وألم في الثديين.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->خفقان (تشعر بضربات قلبك)</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->تغير في وظيفة عمل الكبد، والذي قد يظهر بفحص الدم .</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->الم في الخصيتين.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->استمرارية صعوبة حصول الإنتصاب حتى بعد توقفك عن تناول العلاج.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->استمرارية قلة الرغبة الجنسية حتى بعد توقفك عن تناول العلاج.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->استمرارية مشاكل القذف حتى بعد توقفك عن تناول العلاج.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->قلة الخصوبة لدى الذكور و قلة الجودة المنوية.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->القلق</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-right:-4.5pt" dir="RTL"><strong>&nbsp;</strong>إذا أي من هذه الأعراض الجانبية أصبح اخطر، أو لاحظت ظهور أعراض جانبية غير المذكورة في هذه النشرة، الرجاء اخبر طبيبك أو الصيدلي. وسوف تساعد إذا قمت بتسجيل ماذا حدث، ومتى بدأ ذلك وكم المدة التي&nbsp; استمرت.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>هل استخدام بروبيشيا يؤثر على الشعر في أجزاء أخرى من الجسم؟</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">بروبيشيا لا يؤثر على الشعر في أجزاء الجسم الأخرى.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;<strong>ماذا يجب أن تعرف أيضاً عن بروبيشيا؟</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">فيناسترايد يمكن أن يستخدم أيضا لمشكلة في البروستاتا تسمى (تضخم البروستاتا الحميد) أو BPH. المعلومات التي جُمعت من التجارب السريرية في الرجال الذين يتناولون عقار فيناسترايد ٥ ملغم (هذه الجرعة عبارة عن خمسة أضعاف بروبيشيا ) لمدة سبع سنوات أظهرت:</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->عدد الرجال الذين تطورت حالتهم لسرطان البروستاتا، اقل في الرجال الذين تناولوا فيناسترايد مقارنة مع أولئك الذين لم يتناولوا شيئا.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->عدد الرجال الذين كانوا على درجة عالية على نظام مقياس الورم، كان أعلى في بعض الذين تناولوا فيناسترايد مقارنة بالذين لم يتناولوا شيئا.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->تأثير استخدام فيناسترايد على المدى الطويل على هذا النوع من الأورام غير معروف.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">إذا كنت ترغب في الحصول على مزيد من المعلومات حول نظام مقياس الورم أو هذه التجربة، الرجاء اسأل طبيبك.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية:</strong></p><p dir="RTL">اتّصل بالطبيب أو الصيدلي في حال تعرّضك لأي أعراض جانبيّة محتملة بالإضافة إلى تلك غير المذكورة في هذه النشرة. يمكنك الإبلاغ عن الأعراض الجانبيّة مباشرة من خلال &quot; المركز الوطني للتيقظ والسلامة الدوائية، التابع للهيئة العامة للغذاء والدواء&quot;. يُمكنك تأمين المزيد من المعلومات حول سلامة هذا الدواء من خلال الإبلاغ عن الأعراض الجانبيّة.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">يُحفظ بعيدًا عن متناول أيدي ومرأى الأطفال.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;لا تستخدم بروبيشيا بعد تاريخ انتهاء الصلاحية المذكور على الكرتون بعد حروف EXP. هذا التاريخ مذكور على العبوة الخارجية و الشريط الداخلي.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">لا تضع الأقراص في وعاء آخر، فربما قد تخلط بينهم. لا تقم بإزالة قرص من العلبة حتى تكون مستعداً لتناوله.</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">يُحفظ في درجة حرارة أقل من ٣۰ درجة مئوية . يُحفظ في العبوة الأصلية.</p><p style="margin-right:-4.5pt" dir="RTL">لا يجب التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. هذه التدابير سوف تساعد على حماية البيئة.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="margin-right:-4.5pt" dir="RTL">على ماذا يحتوي بروبيشيا؟</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->المادة الفعالة في أقراص بروبيشيا هي فيناسترايد. كل قرص يحتوي على ۱ ملغم فيناسترايد.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->المكونات الأخرى في بروبيشيا هي: لاكتوز أحادي هيدرات، سيليلوز دقيق البلورات ، نشا الذرة مسبق التجلتن، جلايكوليت نشا الصوديوم، صوديوم دوكيوسيت، مغنيسيوم ستيريت ، و الماء المُنقى، هايبرميلوز &nbsp;، هيدروكسي بروبيل سيليلوز ، تيتانيوم ثنائي التأكسد، تالك، أكسيد الحديد الأصفر172 &nbsp;E ، أكسيد الحديد الأحمر172 &nbsp;E .</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="margin-right:-4.5pt" dir="RTL"><strong>كيف يبدو بروبيشيا وما هي محتويات العلبة:</strong></p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->بروبيشيا متوفرة على شكل أقراص مغلفة ثمانية الجوانب برونزية محدبة، وعليها علامة &#39;P&#39; كشعار من جانب و&quot; PROPECIA &quot;من الجانب الآخر.</p><p style="margin-left:0in; margin-right:-4.5pt; text-indent:0in" dir="RTL"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->أقراص بروبيشيا تزود في عبوات أشرطة من الألمنيوم تحتوي على ۲٨ قرص أو ٨٤ قرص.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>الشركة المالكة لحقوق التسويق </strong><strong>:</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">ميرك شارب و دوم المحدودة،</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">طريق هيرتفورد، هوديسدون،</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">هيرتفوردشاير، إي إن ۱۱ ٩بي يو،</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">المملكة المتحدة</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL"><strong>الشركة المصنعة:</strong></p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">أياك فارما الدولية شركة ذات مسؤولية محدودة</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">الطريق رقم 2، كم 60.3</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">سابانا هويوس</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">اريسيبو، بي أر -00688</p><p style="margin-right:-4.5pt" dir="RTL">بويرتوريكو - الولايات المتحدة الأمريكية</p><p style="margin-left:0in; margin-right:-4.5pt" dir="RTL">&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت أخر مراجعة لهذه النشرة في مايو 2018 الاصدار رقم (3)
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Propecia® 1 mg Film-Coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet of ‘Propecia’ contains 1 mg of finasteride as the active ingredient. Excipients with known effect:
Each  tablet  contains  110.4  mg  of  lactose  monohydrate.  This  medicinal  product
contains less than 1 mmol of sodium per tablet. For a full of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets. Tan octagonal, film-coated, convex tablets, marked with a ‘P’ logo on one side and ‘PROPECIA’ on the other.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&lsquo;Propecia&rsquo; &nbsp;is &nbsp;indicated &nbsp;for &nbsp;the &nbsp;treatment &nbsp;of &nbsp;men &nbsp;with &nbsp;male &nbsp;pattern &nbsp;hair &nbsp;loss (androgenetic alopecia) to increase hair growth and prevent further hair loss.</p><p>&nbsp;</p><p>&lsquo;Propecia&rsquo; is <strong>not </strong>indicated for use in women or children and adolescents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology</p><p>The recommended dosage is one 1 mg tablet daily. &lsquo;Propecia&rsquo; may be taken with or without food.</p><p>&nbsp;</p><p>There is no evidence that an increase in dosage will result in increased efficacy.</p><p>&nbsp;</p><p>Efficacy and duration of treatment should continuously be assessed by the treating physician. Generally, three to six months of once daily treatment are required before evidence of stabilisation of hair loss can be expected. Continuous use is recommended to sustain benefit. If treatment is stopped, the beneficial effects begin to reverse by six months and return to baseline by 9 to 12 months.</p><p>&nbsp;</p><p>Method of administration</p><p>Crushed or broken tablets of &lsquo;Propecia&rsquo; should not be handled by women when they are or may potentially be pregnant because of the possibility of absorption of finasteride and the subsequent potential risk to a male foetus (see section 4.6 Fertility, pregnancy and lactation). &lsquo;Propecia&rsquo; tablets are coated to prevent contact with the</p><p>&nbsp;</p><p>active ingredient during normal handling, provided that the tablets are not broken or crushed.</p><p>&nbsp;</p><p>Patients with renal impairment</p><p>No dosage adjustment is required in patients with renal insufficiency.</p><p>&nbsp;</p><p>No data are available on the concomitant use of &lsquo;Propecia&rsquo; and topical minoxidil in male pattern hair loss.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Contraindicated in women: see 4.6 ‘Fertility, pregnancy and lactation’ and 5.1 ‘Pharmacodynamic properties’.

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. ‘Propecia’ is not indicated for use in women or children and adolescents.
‘Propecia’ should not be taken by men who are taking ‘Proscar’ (finasteride 5 mg) or any other 5-reductase inhibitor for benign prostatic hyperplasia or any other condition.



            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Paediatric population</p><p>&lsquo;Propecia&rsquo; should not be used in children. There are no data demonstrating efficacy or safety of finasteride in children under the age of 18.</p><p>&nbsp;</p><p>Effects on Prostate Specific Antigen (PSA)</p><p>In clinical studies with &lsquo;Propecia&rsquo; in men 18-41 years of age, the mean value of serum prostate-specific antigen (PSA) decreased from 0.7 ng/ml at baseline to 0.5 ng/ml at month 12. Doubling the PSA level in men taking &lsquo;Propecia&rsquo; should be considered before evaluating this test result.</p><p>&nbsp;</p><p>Effects on fertility</p><p>See 4.6 Fertility, pregnancy and lactation</p><p>&nbsp;</p><p>Hepatic impairment</p><p>The effect of hepatic insufficiency on the pharmacokinetics of finasteride has not been studied.</p><p>&nbsp;</p><p>Breast Cancer</p><p>Breast cancer has been reported in men taking finasteride 1 mg during the post- marketing period. Physicians should instruct their patients to promptly report any changes in their breast tissue such as lumps, pain, gynaecomastia or nipple discharge.</p><p>&nbsp;</p><p>Mood alterations and depression</p><p>Mood alterations including depressed mood, depression and, less frequently, suicidal ideation have been reported in patients treated with finasteride 1 mg. Patients should be monitored for psychiatric symptoms and if these occur, treatment with finasteride should be discontinued and the patient advised to seek medical advice.</p><p>&nbsp;</p><p>Lactose intolerance</p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Finasteride is metabolized primarily via, but does not affect, the cytochrome P450 3A4 system. Although the risk for finasteride to affect the pharmacokinetics of other drugs is estimated to be small, it is probable that inhibitors and inducers of cytochrome P450 3A4 will affect the plasma concentration of finasteride. However, based on established safety margins, any increase due to concomitant use of such inhibitors is unlikely to be of clinical significance.</p><p>&nbsp;</p><p>Interaction studies have only been performed in adults</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy &lsquo;Propecia&rsquo; is contra-indicated for use in women due to the risk in pregnancy.</p><p>&nbsp;</p><p>Because of the ability of type II 5a-reductase inhibitors to inhibit conversion of testosterone to dihydrotestosterone (DHT) in some tissues, these drugs, including finasteride, may cause abnormalities of the external genitalia of a male foetus when administered to a pregnant woman.</p><p>&nbsp;</p><p><em>Exposure to finasteride: risk to male foetus</em></p><p>A small amount of finasteride, less than 0.001% of the 1 mg dose per ejaculation, has been detected in the seminal fluid of men taking &lsquo;Propecia&rsquo;. Studies in Rhesus monkeys have indicated that this amount is unlikely to constitute a risk to the developing male foetus (see Section 5.3).</p><p>&nbsp;</p><p>During continual collection of adverse experiences, post-marketing reports of exposure to finasteride during pregnancy via semen of men taking 1 mg or higher doses have been received for eight live male births, and one retrospectively-reported</p><p>case concerned an infant with simple hypospadias. Causality cannot be assessed on the basis of this single retrospective report and hypospadias is a relatively common congenital anomaly with an incidence ranging from 0.8 to 8 per 1000 live male births. In addition, a further nine live male births occurred during clinical trials following exposure to finasteride via semen, during pregnancy, and no congenital anomalies</p><p>have been reported.</p><p>&nbsp;</p><p>&nbsp;</p><p>Breast-feeding</p><p>It is not known whether finasteride is excreted in human milk.</p><p>&nbsp;</p><p>Fertility</p><p>Long-term data on fertility in humans are lacking, and specific studies in subfertile men have not been conducted. The male patients who were planning to father a child were initially excluded from clinical trials. Although, animal studies did not show</p><p>&nbsp;</p><p>relevant negative effects on fertility, spontaneous reports of infertility and /or poor seminal quality were received post-marketing. In some of these reports, patients had other risk factors that might have contributed to infertility. Normalisation or improvement of seminal quality has been reported after discontinuation of finasteride.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Propecia has no or negligible influence on the ability to drive and use machines</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The adverse reactions during clinical trials and/or post-marketing use are listed in the table below.</p><p>&nbsp;</p><p>Frequency of adverse reactions is determined as follows:</p><p>Very Common (&ge; 1/10); Common (&ge; 1/100, &lt; 1/10); Uncommon (&ge; 1/1,000, &lt; 1/100); Rare (&ge;1/10,000, &lt; 1/1,000); Very rare (&lt; 1/10,000); not known (cannot be estimated from the available data).</p><p>The frequency of adverse reactions reported during post-marketing use cannot be determined as they are derived from spontaneous reports.</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:42.35pt; vertical-align:top; width:132.95pt"><p><strong>Immune system</strong><strong> </strong><strong>disorders:</strong></p></td><td style="border-color:black; height:42.35pt; vertical-align:top; width:290.05pt"><p><em>Not known: </em>Hypersensitivity reactions, including rash, pruritus, urticaria and angioedema (swelling of the lips, tongue, throat and face).</p></td></tr><tr><td style="border-color:black; height:41.3pt; vertical-align:top; width:132.95pt"><p><strong>Psychiatric</strong><strong> </strong><strong>disorders:</strong></p></td><td style="height:41.3pt; vertical-align:top; width:290.05pt"><p><em>Uncommon</em>*<em>:</em><em> </em>Decreased libido<em>.</em><em> Uncommon: </em>Depression&dagger;.</p><p><em>Not known:</em><em> </em>Anxiety.</p></td></tr><tr><td style="border-color:black; height:15.7pt; vertical-align:top; width:132.95pt"><p><strong>Cardiac disorder:</strong></p></td><td style="height:15.7pt; vertical-align:top; width:290.05pt"><p><em>Not known: </em>Palpitation</p></td></tr><tr><td style="border-color:black; height:28.55pt; vertical-align:top; width:132.95pt"><p><strong>Hepatobiliary disorders:</strong></p></td><td style="height:28.55pt; vertical-align:top; width:290.05pt"><p><em>Not known: </em>Increased hepatic enzymes.</p></td></tr><tr><td style="border-color:black; height:83.75pt; vertical-align:top; width:132.95pt"><p><strong>Reproductive system</strong><strong> </strong><strong>and breast disorders:</strong></p></td><td style="height:83.75pt; vertical-align:top; width:290.05pt"><p><em>Uncommon</em>*<em>: </em>Erectile dysfunction, ejaculation disorder (including decreased volume of ejaculate).</p><p>&nbsp;</p><p><em>Not known: </em>Breast tenderness and enlargement, Testicular pain, infertility**.</p><p>**See section 4.4.</p></td></tr></tbody></table><p>* Incidences presented as difference from placebo in clinical studies at Month 12.</p><p>&dagger; This adverse reaction was identified through post-marketing surveillance but the incidence in randomized controlled Phase III clinical trials (Protocols 087, 089, and 092) was not different between finasteride and placebo.</p><p>&nbsp;</p><p>Side effects, which usually have been mild, generally have not required discontinuation of therapy.</p><p>&nbsp;</p><p>Finasteride for male pattern hair loss has been evaluated for safety in clinical studies involving more than 3,200 men. In three 12-month, placebo-controlled, double-blind, multicentre studies of comparable design, the overall safety profiles of &lsquo;Propecia&rsquo; and placebo were similar. Discontinuation of therapy due to any clinical adverse experience occurred in 1.7% of 945 men treated with &lsquo;Propecia&rsquo; and 2.1% of 934 men treated with placebo.</p><p>&nbsp;</p><p>In these studies, the following drug-related adverse experiences were reported in <u>&gt;</u>1% of men treated with &lsquo;Propecia&rsquo;: decreased libido (&lsquo;Propecia&rsquo;, 1.8% vs. placebo, 1.3%) and erectile dysfunction (1.3%, 0.7%). In addition, decreased volume of ejaculate was reported in 0.8% of men treated with &lsquo;Propecia&rsquo; and 0.4% of men treated with placebo. Resolution of these side effects occurred in men who discontinued therapy with &lsquo;Propecia&rsquo; and in many who continued therapy. The effect of &lsquo;Propecia&rsquo; on ejaculate volume was measured in a separate study and was not different from that seen with placebo.</p><p>&nbsp;</p><p>By the fifth year of treatment with &lsquo;Propecia&rsquo;, the proportion of patients reporting each of the above side effects decreased to &lt;0.3%.</p><p>&nbsp;</p><p>Finasteride has also been studied for prostate cancer risk reduction at 5 times the dosage recommended for male pattern hair loss. In a 7-year placebo-controlled trial that enrolled 18,882 healthy men, of whom 9060 had prostate needle biopsy data available for analysis, prostate cancer was detected in 803 (18.4%) men receiving finasteride 5 mg and 1147 (24.4%) men receiving placebo. In the finasteride 5 mg group, 280 (6.4%) men had prostate cancer with Gleason scores of 7-10 detected on needle biopsy vs. 237 (5.1%) men in placebo group. Of the total cases of prostate cancer diagnosed in this study, approximately 98% were classified as intracapsular (stage T1 or T2). The relationship between long-term use of finasteride 5 mg and tumours with Gleason scores of 7-10 is unknown.</p><p>&nbsp;</p><p>In addition, the following have been reported in post-marketing use: persistence of sexual dysfunction (decreased libido, erectile dysfunction and ejaculation disorder) after discontinuation of treatment with &lsquo;Propecia&rsquo;; male breast cancer (see 4.4 Special warnings and precautions for use).</p><p>&nbsp;</p><p>Drug-related sexual undesirable effects were more common in the finasteride 1 mg- treated men than the placebo-treated men, with frequencies during the first 12 months of 3.8% vs 2.1%, respectively. The incidence of these effects decreased to 0.6% in finasteride 1 mg-treated men over the following four years. Approximately 1% of men in each treatment group discontinued due to drug related sexual adverse experiences in the first 12 months, and the incidence declined thereafter.</p><p>&nbsp;</p><p>&nbsp;</p><p>Reporting of suspected adverse reactions</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via.</p><p>&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><u>Saudi Arabia: </u></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-20382222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><u>Other GCC States: </u></p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;</strong></p><p style="margin-right:32.6pt; text-align:justify">In clinical studies, single doses of finasteride up to 400 mg and multiple doses of finasteride up to 80 mg/day for three months (n=71) did not result in dose-related undesirable effects.</p><p>&nbsp;</p><p>No specific treatment of overdosage with &lsquo;Propecia&rsquo; is recommended.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: 5&alpha;-reductase inhibitor. ATC code D11AX10 Mechanism of action</p><p>Finasteride is a competitive and specific inhibitor of type II 5a-reductase. Finasteride</p><p>has no affinity for the androgen receptor and has no androgenic, anti-androgenic, oestrogenic, anti-oestrogenic, or progestational effects. Inhibition of this enzyme blocks the peripheral conversion of testosterone to the androgen DHT, resulting in significant decreases in serum and tissue DHT concentrations. Finasteride produces a rapid reduction in serum DHT concentration, reaching significant suppression within 24 hours of dosing.</p><p>&nbsp;</p><p>Hair follicles contain type II 5a-reductase. In men with male pattern hair loss, the balding scalp contains miniaturised hair follicles and increased amounts of DHT. Administration of finasteride decreases scalp and serum DHT concentrations in these men. Men with a genetic deficiency of type II 5a-reductase do not suffer from male pattern hair loss. Finasteride inhibits a process responsible for miniaturisation of the scalp hair follicles, which can lead to reversal of the balding process.</p><p>&nbsp;</p><p>Clinical efficacy and safety</p><p><em>Studies in men</em></p><p>Clinical studies were conducted in 1879 men aged 18 to 41 with mild to moderate, but not complete, vertex hair loss and/or frontal/mid-area hair loss. In the two studies in men with vertex hair loss (n=1553), 290 men completed 5 years of treatment with Propecia vs. 16 patients on placebo. In these two studies, efficacy was assessed by the following methods: (i) hair count in a representative 5.1cm2&nbsp;area of scalp, (ii) patient self assessment questionnaire, (iii) investigator assessment using a seven point scale, and (iv) photographic assessment of standardised paired photographs by a blinded expert panel of dermatologists using a seven point scale.</p><p>&nbsp;</p><p>In these 5- year studies men treated with &lsquo;Propecia&rsquo; improved compared to both baseline and placebo beginning as early as 3 months, as determined by both the patient and investigator assessments of efficacy. With regard to hair count, the primary endpoint in these studies, increases compared to baseline were demonstrated starting</p><p>at 6 months (the earliest time point assessed) through to the end of the study. In men treated with &lsquo;Propecia&rsquo; these increases were greatest at 2 years and gradually declined thereafter to the end of 5 years; whereas hair loss in the placebo group progressively worsened compared to baseline over the entire 5 year period. In &lsquo;Propecia&rsquo; treated patients, a mean increase from baseline of 88 hairs [<em>p &lt;0.01; 95% CI (77.9, 97.80; n=433] </em>in the representative 5.1 cm2&nbsp;area was observed at 2 years and an increase from baseline of 38 hairs <em>[p &lt;0.01; 95% CI (20.8, 55.6); </em><em>n=219]</em><em> </em>was observed at 5 years, compared with a decrease from baseline of 50 hairs <em>[p &lt;0.01; 95% CI (-80.5,</em></p><p><em>-20.6);n=47] </em>at 2 years and a decrease from baseline of 239 hairs <em>[p &lt;0.01; 95% CI (-304.4, -173.4); n=15] </em>at 5 years in patients who received placebo. Standardised photographic assessment of efficacy demonstrated that 48% of men treated with finasteride for 5 years were rated as improved, and an additional 42% were rated as</p><p>unchanged. This is in comparison to 25% of men treated with placebo for 5 years who were rated as improved or unchanged. These data demonstrate that treatment with &lsquo;Propecia&rsquo; for 5 years resulted in a stabilisation of the hair loss that occurred in men treated with placebo.</p><p>&nbsp;</p><p>An additional 48-week, placebo-controlled study designed to assess the effect of &lsquo;Propecia&rsquo; on the phases of the hair-growth cycle (growing phase [anagen] and resting phase [telogen]) in vertex baldness enrolled 212 men with androgenetic alopecia. At baseline and 48 weeks, total, anagen and telogen hair counts were obtained in a 1-cm2&nbsp;target area of the scalp. Treatment with &lsquo;Propecia&rsquo; led to improvements in anagen hair counts, while men in the placebo group lost anagen hair. At 48 weeks, men treated with &lsquo;Propecia&rsquo; showed net increases in total and anagen hair counts of 17 hairs and 27 hairs, respectively, compared to placebo. This increase in anagen hair count, compared to total hair count, led to a net improvement in the anagen-to-telogen ratio of 47% at 48 weeks for men treated with &lsquo;Propecia&rsquo;, compared to placebo. These data provide direct evidence that treatment with &lsquo;Propecia&rsquo; promotes the conversion of hair follicles into the actively growing phase.</p><p>&nbsp;</p><p><em>Studies in women</em></p><p>Lack of efficacy was demonstrated in post-menopausal women with androgenetic alopecia who were treated with &lsquo;Propecia&rsquo; in a 12 month, placebo-controlled study (n=137). These women did not show any improvement in hair count, patient self- assessment, investigator assessment, or ratings based on standardised photographs, compared with the placebo group.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Relative to an intravenous reference dose, the oral bioavailability of finasteride is approximately 80%. The bioavailability is not affected by food. Maximum finasteride plasma concentrations are reached approximately two hours after dosing and the absorption is complete after six to eight hours.</p><p>&nbsp;</p><p>Distribution</p><p>Protein binding is approximately 93%. The volume of distribution of finasteride is approximately 76 litres.</p><p>&nbsp;</p><p>At steady state following dosing with 1 mg/day, maximum finasteride plasma concentration averaged 9.2 ng/ml and was reached 1 to 2 hours post-dose; AUC (0-24&nbsp;hr) was 53 ng&middot;hr/ml.</p><p>&nbsp;</p><p>Finasteride has been recovered in the cerebrospinal fluid (CSF), but the drug does not appear to concentrate preferentially to the CSF. A small amount of finasteride has also been detected in the seminal fluid of subjects receiving the drug.</p><p>&nbsp;</p><p>Biotransformation</p><p>Finasteride is metabolised primarily via the cytochrome P450 3A4 enzyme subfamily. Following an oral dose of 14C-finasteride in man, two metabolites of the drug were identified that possess only a small fraction of the 5a-reductase inhibitory activity of finasteride.</p><p>&nbsp;</p><p>Elimination</p><p>Following an oral dose of 14C-finasteride in man, 39% of the dose was excreted in the urine in the form of metabolites (virtually no unchanged drug was excreted in the urine) and 57% of total dose was excreted in the faeces.</p><p>&nbsp;</p><p>Plasma clearance is approximately 165 ml/min.</p><p>&nbsp;</p><p>The elimination rate of finasteride decreases somewhat with age. Mean terminal half- life is approximately 5-6 hours in men 18-60 years of age and 8 hours in men more than 70 years of age. These findings are of no clinical significance and hence, a reduction in dosage in the elderly is not warranted.</p><p>&nbsp;</p><p>Renal impairment</p><p>No adjustment in dosage is necessary in non-dialysed patients with renal impairment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In general, the findings in laboratory animal studies with oral finasteride were related to the pharmacological effects of 5a-reductase inhibition.</p><p>&nbsp;</p><p>Intravenous administration of finasteride to pregnant rhesus monkeys at doses as high as 800 ng/day during the entire period of embryonic and foetal development resulted in no abnormalities in male foetuses. This represents at least 750 times the highest estimated exposure of pregnant women to finasteride from semen. In confirmation of the relevance of the Rhesus model for human foetal development, oral administration of finasteride 2 mg/kg/day (100 times the recommended human dose or approximately</p><p>12 million times the highest estimated exposure to finasteride from semen) to pregnant monkeys resulted in external genital abnormalities in male foetuses. No other abnormalities were observed in male foetuses and no finasteride-related abnormalities were observed in female foetuses at any dose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet core:</p><p>Lactose, microcrystalline cellulose E460, pregelatinised maize starch, sodium starch glycollate, docusate sodium, magnesium stearate E572,</p><p>&nbsp;</p><p>Coating:</p><p>hypromellose E464, hydroxypropyl cellulose E463, titanium dioxide, talc, yellow iron oxide E172, red iron oxide E172.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C. Store in original package.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminium blisters lidded with aluminium foil, containing 28 tablets or 84 tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Crushed or broken tablets of &lsquo;Propecia&rsquo; should not be handled by women when they are or may potentially be pregnant (see 4.6 &lsquo;Pregnancy and lactation&rsquo;).</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
Marketing Authorisation Holder
Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, UK.

Manufacturer
AIAC International Pharma LLC,
Road No 2, Kilometer  60.3, Sabana Hoyos, 
Arecibo, PR-00688,
Puerto Rico-USA


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                19 June 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>